Genital neoplasia

• FC 03-01 • Vulvar cancer: two pathways with different localization and prognosis See abstract > F. F. HINTEN • FC 03-02 • The role of the antileukoprotease secretory leukocyte protease inhibitor (SLPI) in squamous cell carcinoma of the vulva in relation to HPV-infection and smoking habit of the patients See abstract > E. E.S. QUABIUS • FC 03-03 • DNA copy number aberrations associated with HPV-dependent and -independent vulvar carcinogenesis See abstract > D. D. SWARTS • FC 03-04 • Does HPV genotype affects the grade and the risk of recurrence of vaginal intraepithelial neoplasia? See abstract > A. A.D. IACOBONE • FC 03-05 • Distribution of high-risk HPV types in women with invasive cervical carcinoma in Kazakhstan See abstract > A. Anja Šterbenc • FC 03-06 • Physical activity, obesity and cervical cancer in Germany See abstract > L. L. LIANG • FC 03-07 • Ten years study of invasive cervical cancer: microinvasive cases increase in co-testing period See abstract > R. R. ONCINS • FC 03-08 • What is the impact of the HPV vaccination program on the natural history of high grade squamous intraepithelial cervical lesions in New Zealand? See abstract > P. P. SYKES • FC 03-09 • Preterm delivery and perinatal outcome after conization: a retrospective analysis of the national inpatient quality survey data in Germany; 2009- 2014. See abstract > C. C. DANNECKER • FC 03-10 • Correlation of isotope count with sentinel node positivity in vulvar cancer See abstract > K. K. PRIESKE